Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,961–8,980 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Trimix ST9D 30PA-2PH-150A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1311-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phentolamine 1 mg/Papaverine 15 mg/Alprostadil 150 mcg Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1308-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix ST-9B 30 PA-2PH-100A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1344-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1388-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Papaverine/Phentolamine/Alprostadil/Lidocaine 30 mg/1 mg/175 mcg/1 mg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1369-02

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/60 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1367-02

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1366-02

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/10 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1365-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix AT-6 Papa 30 mg/Phent 4 mg/Atrop. 0.3 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1343-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Alprostadil/ Phentolamine/Papavarin 40 mcg/1 mg/30 mg 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1330-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix 30-1-30 Papavarin 30 mg/Phentolamine 1 mg/Alprostadil 30 mg/mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1319-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix T 101 Alprostadil/Papverine/Phentolamine 5.9 mcg/17.65 mg/0.59 mcg per mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1336-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix BM3 Papaverine 30 mg/Phentolamine 1 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1354-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Tri-Mix XL 150 mg/10 mg/100 mcg a) Injectable NDC 69699-1353-10; b) (LYO) Powder NDC 69699-1353-10, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Tilarginine Acetate 50 mg/mL, 10 mL, Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1461-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sterile Water 50 mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1421-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

0.9% Sodium Chloride for Injection, 50 mL bags, Pharm D Solutions, Houston, Texas --- NDC 69699-1426-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.